Walleye Capital
DRUG

Walleye Capital’s Bright Minds Biosciences DRUG Stock Holding History

Walleye Capital’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.64M Buy
66,106
+12,400
+23% +$974K 0.02% 871
2026
Q1 		$3.92M Buy
53,706
+27,880
+108% +$2.24M 0.02% 964
2025
Q4 		$2.02M Sell
25,826
-46,928
-65% -$3.14M 0.01% 1870
2025
Q3 		$4.41M Buy
72,754
+19,324
+36% +$750K 0.02% 1000
2025
Q2 		$1.4M Sell
53,430
-31,592
-37% -$947K 0.01% 1790
2025
Q1 		$3.07M Sell
85,022
-18,170
-18% -$665K 0.01% 1121
2024
Q4 		$3.72M Buy
+103,192
New +$3.63M 0.01% 1280

Other funds holding DRUG

Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
SIC
SJS Investment Consulting Sylvania, Ohio $919M AUM 23.4% 1-Year Est. Return

Walleye Capital's DRUG Position: Q2 2026 in Review

Walleye Capital increased its Bright Minds Biosciences (DRUG) stake by 23% in Q2 2026, buying an estimated $974K and bringing the position to 66,106 shares worth $4.64M. The position accounts for 0.02% of the portfolio, ranked #871.

Walleye Capital first reported a position in DRUG in Q4 2024 and has held it in 7 quarters since. 11 funds tracked by Wall St. Rank hold DRUG as of Q2 2026.

  • Walleye Capital held 66,106 shares of Bright Minds Biosciences worth $4.64M as of Q2 2026.
  • Walleye Capital bought 12,400 Bright Minds Biosciences shares in Q2 2026, an estimated $974K.
  • Bright Minds Biosciences made up 0.02% of Walleye Capital's portfolio in Q2 2026, its #871 holding.
  • Walleye Capital first reported a position in Bright Minds Biosciences in Q4 2024 and has held it in 7 quarters since.
  • 11 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.